Wird geladen...
Denosumab: a new agent in the management of hypercalcemia of malignancy
Hypercalcemia of malignancy is an oncologic emergency due to tumoral factors that stimulate osteoclast-mediated bone resorption. It requires a combination of recommended treatments (i.e., hydration, bisphosphonate and calcitonin), which may be deleterious in patients with compromised cardiac or rena...
Gespeichert in:
| Veröffentlicht in: | Future Oncol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Future Medicine Ltd
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976858/ https://ncbi.nlm.nih.gov/pubmed/26403973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.15.232 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|